Swiss life science and biotech company Arcoris Bio completed a CHF 6.3m seed financing round. In connection with the operation, Wenger Vieli advised Arcoris Bio, while MLL Legal represented German biotech investment fund Ventura Ace
Tags :Wenger Vieli
Wenger Vieli advised DeepJudge, a Zurich-based specialist in legal AI platforms, throughout its USD 41.2 million series A financing round. Silicon Valley venture capital firm Felicis led the round in question, with further support from existing
Mimic Robotics – a Swiss physical AI company developing dexterous robotic systems – completed a USD 16 million seed financing round. In connection with the operation, Wenger Vieli advised Mimic Robotics, while id est avocats represented lead investor
Wenger Vieli advised TRI Dental Implants, a Hünenberg-based provider of digital dental implant solutions, on a minority investment in the company by Swiss medtech specialist in medical regeneration Geistlich Pharma. The Wenger Vieli team
Wenger Vieli advised Beyond Gravity on the sale and lease-back of a 37,500 m² industrial and development site in Zurich-Seebach, popularly known as the “former Contraves site”, to the City of Zurich. A subsidiary of Swiss
Wenger Vieli advised the shareholders of N-Dream, the Swiss company behind the in-car gaming platform AirConsole, in connection with the sale to software-defined vehicle development specialist KPIT Technologies. Pursuant to the deal KPIT increases its
Corintis – a Swiss deep-tech start-up specialising in microfluidic cooling technologies – has recently completed a USD 24m Series a financing round. Wenger Vieli advised Corintis throughout the operation, while MLL Legal advised BlueYard Capital in connection
Wenger Vieli advised the shareholders of Tripleblue, a provider of AI solutions with a focus on HOA management, in connection with its sale to property-tech specialist Aareon. The Wenger Vieli team Partner Michael Baier (corporate/
Wenger Vieli advised the shareholders of Swiss-based individualised rehabilitation specialist SKS Rehab in connection with its merger with Roltec El-Kørestole, leading to the formation of the new SKS Roltec Group. Moreover, the SKS Roltec
DBAG Fund VIII, a private equity fund advised by Deutsche Beteiligungs (DBAG), has entered in an agreement to acquire MAIT Group from 3i Group. In connection with the deal, Bär & Karrer is representing
